Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review
Authors
Keywords
-
Journal
Current Pain and Headache Reports
Volume 25, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-25
DOI
10.1007/s11916-020-00934-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Treatment of Chronic Pain With Various Buprenorphine Formulations
- (2018) Rohit Aiyer et al. ANESTHESIA AND ANALGESIA
- Levorphanol for Treatment of Intractable Neuropathic Pain in Cancer Patients
- (2018) Akhila Reddy et al. JOURNAL OF PALLIATIVE MEDICINE
- The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine
- (2018) Stephen Chin Beng Lim et al. PAIN MEDICINE
- NMDA Receptor Activation Underlies the Loss of Spinal Dorsal Horn Neurons and the Transition to Persistent Pain after Peripheral Nerve Injury
- (2018) Perrine Inquimbert et al. Cell Reports
- Designing safer analgesics: a focus on μ-opioid receptor pathways
- (2018) Joseph V. Pergolizzi et al. Expert Opinion on Drug Discovery
- Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians
- (2018) C. Holly A. Andrilla et al. JOURNAL OF RURAL HEALTH
- Advances in the delivery of buprenorphine for opioid dependence
- (2017) Richard Rosenthal et al. Drug Design Development and Therapy
- Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain
- (2016) Richard W. Simpson et al. DIABETES CARE
- Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects
- (2016) Yi Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Neuropathic Pain
- (2016) Ralf Baron et al. SEMINARS IN NEUROLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- Levorphanol use: past, present and future
- (2015) Jeffrey Gudin et al. POSTGRADUATE MEDICINE
- Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial
- (2015) Ralf Baron et al. Pain Practice
- Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study
- (2015) Ralf Baron et al. Pain Practice
- Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study
- (2014) Ralf Baron et al. Pain Practice
- Neuropathic pain in the general population: A systematic review of epidemiological studies
- (2013) O. van Hecke et al. PAIN
- Pharmacology Update
- (2012) Deidre M. Pierce et al. American Journal of Hospice & Palliative Medicine
- Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study
- (2012) A. Vinik et al. JOURNAL OF PAIN
- Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically Active
- (2011) Sarah M. Brown et al. ANESTHESIOLOGY
- The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice
- (2011) Babette Kögel et al. NEUROSCIENCE LETTERS
- The specific disease burden of neuropathic pain: Results of a French nationwide survey
- (2011) Nadine Attal et al. PAIN
- Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
- (2010) Sherwyn Schwartz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Tapentadol immediate-release for acute pain
- (2010) Craig T Hartrick Expert Review of Neurotherapeutics
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
- (2009) Alban Latremoliere et al. JOURNAL OF PAIN
- Short- and intermediate-term efficacy of buprenorphine TDS in chronic painful neuropathies
- (2009) Paola Penza et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search